Beijing Biostar Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Beijing Biostar Pharmaceuticals has a total shareholder equity of CN¥723.2M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥772.3M and CN¥49.2M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥576.02m |
| Equity | CN¥723.16m |
| Total liabilities | CN¥49.18m |
| Total assets | CN¥772.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2563's short term assets (CN¥633.5M) exceed its short term liabilities (CN¥43.7M).
Long Term Liabilities: 2563's short term assets (CN¥633.5M) exceed its long term liabilities (CN¥5.4M).
Debt to Equity History and Analysis
Debt Level: 2563 is debt free.
Reducing Debt: 2563 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 2563 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2563 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.